These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 20065518

  • 21. Targeted proteomics: a bridge between discovery and validation.
    Harlan R, Zhang H.
    Expert Rev Proteomics; 2014 Dec; 11(6):657-61. PubMed ID: 25348939
    [Abstract] [Full Text] [Related]

  • 22. A novel liquid chromatography/tandem mass spectrometry method for the quantification of glycine as biomarker in brain microdialysis and cerebrospinal fluid samples within 5min.
    Voehringer P, Fuertig R, Ferger B.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov 15; 939():92-7. PubMed ID: 24121745
    [Abstract] [Full Text] [Related]

  • 23. Discovery of regulatory molecular events and biomarkers using 2D capillary chromatography and mass spectrometry.
    Powell DW, Merchant ML, Link AJ.
    Expert Rev Proteomics; 2006 Feb 15; 3(1):63-74. PubMed ID: 16445351
    [Abstract] [Full Text] [Related]

  • 24. System suitability in bioanalytical LC/MS/MS.
    Briscoe CJ, Stiles MR, Hage DS.
    J Pharm Biomed Anal; 2007 Jun 28; 44(2):484-91. PubMed ID: 17433601
    [Abstract] [Full Text] [Related]

  • 25. Dansylation isotope labeling liquid chromatography mass spectrometry for parallel profiling of human urinary and fecal submetabolomes.
    Su X, Wang N, Chen D, Li Y, Lu Y, Huan T, Xu W, Li L, Li L.
    Anal Chim Acta; 2016 Jan 15; 903():100-9. PubMed ID: 26709303
    [Abstract] [Full Text] [Related]

  • 26. Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome.
    Xu W, Chen D, Wang N, Zhang T, Zhou R, Huan T, Lu Y, Su X, Xie Q, Li L, Li L.
    Anal Chem; 2015 Jan 20; 87(2):829-36. PubMed ID: 25486321
    [Abstract] [Full Text] [Related]

  • 27. Increased confidence in large-scale phosphoproteomics data by complementary mass spectrometric techniques and matching of phosphopeptide data sets.
    Alcolea MP, Kleiner O, Cutillas PR.
    J Proteome Res; 2009 Aug 20; 8(8):3808-15. PubMed ID: 19537829
    [Abstract] [Full Text] [Related]

  • 28. Biomarker Assay Validation by Mass Spectrometry.
    Fernández-Metzler C, Ackermann B, Garofolo F, Arnold ME, DeSilva B, Gu H, Laterza O, Mao Y, Rose M, Vazvaei-Smith F, Steenwyk R.
    AAPS J; 2022 May 09; 24(3):66. PubMed ID: 35534647
    [Abstract] [Full Text] [Related]

  • 29. Methodological advances in the discovery of protein and peptide disease markers.
    Bischoff R, Luider TM.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr 15; 803(1):27-40. PubMed ID: 15025996
    [Abstract] [Full Text] [Related]

  • 30. An automated high throughput liquid chromatography-mass spectrometry process to assess the metabolic stability of drug candidates.
    Drexler DM, Belcastro JV, Dickinson KE, Edinger KJ, Hnatyshyn SY, Josephs JL, Langish RA, McNaney CA, Santone KS, Shipkova PA, Tymiak AA, Zvyaga TA, Sanders M.
    Assay Drug Dev Technol; 2007 Apr 15; 5(2):247-64. PubMed ID: 17477833
    [Abstract] [Full Text] [Related]

  • 31. Difference detection in LC-MS data for protein biomarker discovery.
    Listgarten J, Neal RM, Roweis ST, Wong P, Emili A.
    Bioinformatics; 2007 Jan 15; 23(2):e198-204. PubMed ID: 17237092
    [Abstract] [Full Text] [Related]

  • 32. Recent development in high-throughput bioanalytical support for in vitro ADMET profiling.
    Shou WZ, Zhang J.
    Expert Opin Drug Metab Toxicol; 2010 Mar 15; 6(3):321-36. PubMed ID: 20163321
    [Abstract] [Full Text] [Related]

  • 33. Integrating qualitative and quantitative liquid chromatography/tandem mass spectrometric analysis to support drug discovery.
    Poon GK, Kwei G, Wang R, Lyons K, Chen Q, Didolkar V, Hop CE.
    Rapid Commun Mass Spectrom; 1999 Mar 15; 13(19):1943-50. PubMed ID: 10487941
    [Abstract] [Full Text] [Related]

  • 34. Quantitative Clinical Chemistry Proteomics (qCCP) using mass spectrometry: general characteristics and application.
    Lehmann S, Hoofnagle A, Hochstrasser D, Brede C, Glueckmann M, Cocho JA, Ceglarek U, Lenz C, Vialaret J, Scherl A, Hirtz C, IFCC Working Group on Clinical Quantitative Mass Spectrometry Proteomics (WG-cMSP).
    Clin Chem Lab Med; 2013 May 15; 51(5):919-35. PubMed ID: 23183755
    [Abstract] [Full Text] [Related]

  • 35. High-throughput liquid chromatography/mass spectrometry method for the quantitation of small molecules using accurate mass technologies in supporting discovery drug screening.
    Ding X, Ghobarah H, Zhang X, Jaochico A, Liu X, Deshmukh G, Liederer BM, Hop CE, Dean B.
    Rapid Commun Mass Spectrom; 2013 Feb 15; 27(3):401-8. PubMed ID: 23280971
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of urinary ribonucleoside profiling for clinical biomarker discovery using constant neutral loss scanning liquid chromatography/tandem mass spectrometry.
    Teichert F, Winkler S, Keun HC, Steward WP, Gescher AJ, Farmer PB, Singh R.
    Rapid Commun Mass Spectrom; 2011 Jul 30; 25(14):2071-82. PubMed ID: 21698690
    [Abstract] [Full Text] [Related]

  • 37. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH, Gerona R, Armenian P, French D, Petrie M, Lynch KL.
    Clin Toxicol (Phila); 2012 Sep 30; 50(8):733-42. PubMed ID: 22888997
    [Abstract] [Full Text] [Related]

  • 38. Application and challenges in using LC-MS assays for absolute quantitative analysis of therapeutic proteins in drug discovery.
    Zheng J, Mehl J, Zhu Y, Xin B, Olah T.
    Bioanalysis; 2014 Mar 30; 6(6):859-79. PubMed ID: 24702115
    [Abstract] [Full Text] [Related]

  • 39. Label-free mass spectrometry-based proteomics for biomarker discovery and validation.
    Pham TV, Piersma SR, Oudgenoeg G, Jimenez CR.
    Expert Rev Mol Diagn; 2012 May 30; 12(4):343-59. PubMed ID: 22616700
    [Abstract] [Full Text] [Related]

  • 40. Comparison of bioanalytical methods for the quantitation of PEGylated human insulin.
    de Dios K, Manibusan A, Marsden R, Pinkstaff J.
    J Immunol Methods; 2013 Oct 31; 396(1-2):1-7. PubMed ID: 23933323
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.